MiMedx Group MDXG Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $389.42M+10.5% | $418.63M+20.0% | $393.44M+14.8% | $363.77M+6.8% | $352.38M+5.3% | ||
| $73.82M+16.0% | $73.01M+21.5% | $70.87M+24.3% | $67.47M+19.5% | $63.64M+15.3% | ||
| $315.59M+9.3% | $345.62M+19.7% | $322.58M+12.9% | $296.3M+4.3% | $288.73M+3.4% | ||
| 81%-0.9pp | 82.6%-0.2pp | 82%-1.4pp | 81.5%-2.0pp | 81.9%-1.6pp | ||
| $15.91M+24.0% | $15.1M+22.3% | $13.91M+24.1% | $13.12M+15.5% | $12.83M+6.7% | ||
| $259.46M+12.8% | $266.19M+18.3% | $254.16M+16.4% | $238.68M+9.8% | $229.93M+7.4% | ||
| $39.59M-26.6% | $63.89M+8.5% | $53.87M-14.9% | $42.84M-32.3% | $53.92M+6.4% | ||
| 10.2%-5.1pp | 15.3%-1.6pp | 13.7%-4.8pp | 11.8%-6.8pp | 15.3%+0.2pp | ||
| $3.31M— | $2.93M— | —— | —— | —— | ||
| -$581K+4.9% | -$558K+1.2% | -$580K— | -$475K— | -$611K— | ||
| $42.32M-22.3% | $66.26M+15.7% | $55.72M-7.1% | $44.29M-23.6% | $54.5M+24.0% | ||
| $11.62M-20.0% | $17.68M+15.6% | $14.89M+158% | $12.33M+143% | $14.54M+142% | ||
| $0.20-25.9% | $0.32+14.3% | $0.27-55.0% | $0.21-65.6% | $0.27-46.0% | ||
| $51.05M-17.9% | $78.77M+21.4% | $66.54M-3.1% | $53.3M-21.6% | $62.17M+13.6% | ||
| 13.1%-4.5pp | 18.8%+0.2pp | 16.9%-3.1pp | 14.7%-5.3pp | 17.6%+1.3pp | ||
| $39.59M-26.6% | $63.89M+8.5% | $53.87M-14.9% | $42.84M-32.3% | $53.92M+6.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is MiMedx Group's revenue?
- MiMedx Group (MDXG) generated $389.4M in revenue over the trailing twelve months, up 10.5% year over year.
- Is MiMedx Group profitable?
- MiMedx Group reported $30.7M in net income over the trailing twelve months, a 7.9% net margin.
- What are MiMedx Group's profit margins?
- Gross margin is 81.0% and operating margin is 10.2%, with a 7.9% net margin.
- What is MiMedx Group's earnings per share?
- MiMedx Group's diluted EPS over the trailing twelve months is $0.20.
- Where does MiMedx Group's income statement data come from?
- Every line is extracted from MiMedx Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
